The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 30, 2023
Filed:
Mar. 11, 2019
Applicant:
Viacyte, Inc., San Diego, CA (US);
Inventors:
Laura Martinson, San Diego, CA (US);
Chad Green, San Diego, CA (US);
Evert Kroon, San Diego, CA (US);
Emmanuel Edward Baetge, San Diego, CA (US);
Assignee:
ViaCyte, Inc., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61F 2/00 (2006.01); C12N 5/02 (2006.01); A61L 27/38 (2006.01); A61K 35/39 (2015.01); C12N 5/071 (2010.01); A61L 27/14 (2006.01); A61L 27/54 (2006.01); A01N 1/02 (2006.01); A61K 38/28 (2006.01); A61M 5/00 (2006.01); A61F 2/02 (2006.01); A61L 27/50 (2006.01); A61L 27/56 (2006.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61L 27/3804 (2013.01); A01N 1/0221 (2013.01); A61F 2/022 (2013.01); A61K 35/39 (2013.01); A61K 38/28 (2013.01); A61L 27/14 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61M 5/00 (2013.01); A61M 31/002 (2013.01); C12N 5/0676 (2013.01); C12N 5/0678 (2013.01); A61K 2035/126 (2013.01); A61L 2300/252 (2013.01); A61L 2300/62 (2013.01); A61L 2300/64 (2013.01); A61M 31/00 (2013.01); A61M 2202/07 (2013.01); A61M 2205/04 (2013.01); C12N 2501/115 (2013.01); C12N 2501/117 (2013.01); C12N 2501/119 (2013.01); C12N 2501/16 (2013.01); C12N 2501/19 (2013.01); C12N 2501/385 (2013.01); C12N 2501/41 (2013.01); C12N 2501/415 (2013.01); C12N 2506/02 (2013.01);
Abstract
The present invention relates to a cryopreserved in vitro cell culture comprising human pancreatic progenitor cells that co-express pancreatic-duodenal homeobox factor-1 (PDX1) and NK6 homeobox 1 (NKX6.1) and are chromogranin negative. The present invention also relates to a method for cryopreserving an in vitro population of human pancreatic progenitor cells that co-express PDX1 and NKX6.1 and are chromogranin negative.